lemborexantbuprenorphineBUPVirginia Commonwealth University Institutional Review Boardopioid use disorderinsomniaOUDFood and Drug AdministrationFDAFDA
…or at least 4 weeks will be randomly assigned to receive either lemborexant (n=50) or placebo (n=50) for 8 weeks. Participants will complet…